Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Thezenas

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Breast Cancer Research and Treatment|May 12, 2016
Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastasesWilliam Jacot, Elvire Pons, Jean-Sébastien Frenel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 16, 2020
Intraoperative partial irradiation for highly selected patients with breast cancer: Results of the INTRAOBS prospective studyClaire Lemanski, Celine Bourgier, Roxanna Draghici, et al.
Annals of Surgical Oncology|August 20, 2013
A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trialMarc Ychou, Michel Rivoire, Simon Thezenas, et al.
Bulletin Du Cancer|August 29, 2007
[Positive sentinel node biopsy in breast cancer: is axillary surgery necessary in all cases?]Frédéric Trentini, Bernard Saint-Aubert, François Quenet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2009
Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecanFrédéric Bibeau, Evelyne Lopez-Crapez, Frédéric Di Fiore, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 17, 2024
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patientsEmmanuelle Samalin, Thibault Mazard, Eric Assenat, et al.
Journal of Neuro-Oncology|March 1, 2018
Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancerAmélie Darlix, Gaia Griguolo, Simon Thezenas, et al.
Journal of Neuro-Oncology|January 3, 2025
The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factorsViolaine Randrian, Fabienne Portales, Olivier Bouché, et al.
Journal of Pain and Symptom Management|August 6, 2017
Management of Cancer Cachexia and Guidelines Implementation in a Comprehensive Cancer Center: A Physician-Led Cancer Nutrition Program Adapted to the Practices of a CountryPierre Senesse, Agnès Isambert, Chloé Janiszewski, et al.
Scientific Reports|March 28, 2019
Quantifying circulating cell-free DNA in humansRomain Meddeb, Zahra Al Amir Dache, Simon Thezenas, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Breast Cancer Research and Treatment|May 12, 2016
Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastasesWilliam Jacot, Elvire Pons, Jean-Sébastien Frenel, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 16, 2020
Intraoperative partial irradiation for highly selected patients with breast cancer: Results of the INTRAOBS prospective studyClaire Lemanski, Celine Bourgier, Roxanna Draghici, et al.
Annals of Surgical Oncology|August 20, 2013
A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trialMarc Ychou, Michel Rivoire, Simon Thezenas, et al.
Bulletin Du Cancer|August 29, 2007
[Positive sentinel node biopsy in breast cancer: is axillary surgery necessary in all cases?]Frédéric Trentini, Bernard Saint-Aubert, François Quenet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2009
Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecanFrédéric Bibeau, Evelyne Lopez-Crapez, Frédéric Di Fiore, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 17, 2024
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patientsEmmanuelle Samalin, Thibault Mazard, Eric Assenat, et al.
Journal of Neuro-Oncology|March 1, 2018
Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancerAmélie Darlix, Gaia Griguolo, Simon Thezenas, et al.
Journal of Neuro-Oncology|January 3, 2025
The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factorsViolaine Randrian, Fabienne Portales, Olivier Bouché, et al.
Journal of Pain and Symptom Management|August 6, 2017
Management of Cancer Cachexia and Guidelines Implementation in a Comprehensive Cancer Center: A Physician-Led Cancer Nutrition Program Adapted to the Practices of a CountryPierre Senesse, Agnès Isambert, Chloé Janiszewski, et al.
Scientific Reports|March 28, 2019
Quantifying circulating cell-free DNA in humansRomain Meddeb, Zahra Al Amir Dache, Simon Thezenas, et al.
Pageof 6